Profound Medical Corp. (TSX:PRN)

Profound Medical Statistics

Total Valuation

TSX:PRN has a market cap or net worth of CAD 316.11 million. The enterprise value is 288.16 million.

Market Cap	316.11M
Enterprise Value	288.16M

Important Dates

The next estimated earnings date is Friday, March 13, 2026.

Earnings Date	Mar 13, 2026
Ex-Dividend Date	n/a

Share Statistics

TSX:PRN has 36.29 million shares outstanding. The number of shares has increased by 22.70% in one year.

Current Share Class	36.29M
Shares Outstanding	36.29M
Shares Change (YoY)	+22.70%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	4.06%
Owned by Institutions (%)	39.87%
Float	34.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.87
PB Ratio	7.06
P/TBV Ratio	7.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.26
EV / Sales	14.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.15.

Current Ratio	4.18
Quick Ratio	3.32
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -124.49% and return on invested capital (ROIC) is -71.15%.

Return on Equity (ROE)	-124.49%
Return on Assets (ROA)	-62.44%
Return on Invested Capital (ROIC)	-71.15%
Return on Capital Employed (ROCE)	-130.47%
Weighted Average Cost of Capital (WACC)	6.10%
Revenue Per Employee	140,240
Profits Per Employee	-385,909
Employee Count	142
Asset Turnover	0.34
Inventory Turnover	0.53

Taxes

Income Tax	-16,715
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.82% in the last 52 weeks. The beta is 0.36, so TSX:PRN's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	+0.82%
50-Day Moving Average	10.24
200-Day Moving Average	8.21
Relative Strength Index (RSI)	32.93
Average Volume (20 Days)	19,811

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:PRN had revenue of CAD 19.91 million and -54.80 million in losses. Loss per share was -1.89.

Revenue	19.91M
Gross Profit	14.44M
Operating Income	-58.82M
Pretax Income	-54.82M
Net Income	-54.80M
EBITDA	-57.86M
EBIT	-58.82M
Loss Per Share	-1.89

Balance Sheet

The company has 34.58 million in cash and 6.63 million in debt, with a net cash position of 27.95 million or 0.77 per share.

Cash & Cash Equivalents	34.58M
Total Debt	6.63M
Net Cash	27.95M
Net Cash Per Share	0.77
Equity (Book Value)	44.77M
Book Value Per Share	1.48
Working Capital	44.00M

Cash Flow

Operating Cash Flow	-52.26M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 72.49%, with operating and profit margins of -295.38% and -275.18%.

Gross Margin	72.49%
Operating Margin	-295.38%
Pretax Margin	-275.26%
Profit Margin	-275.18%
EBITDA Margin	-290.56%
EBIT Margin	-295.38%
FCF Margin	n/a

Dividends & Yields

TSX:PRN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.70%
Shareholder Yield	-22.70%
Earnings Yield	-17.34%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 16, 2019. It was a reverse split with a ratio of 0.1.

Last Split Date	Oct 16, 2019
Split Type	Reverse
Split Ratio	0.1

Scores

TSX:PRN has an Altman Z-Score of -0.7 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.7
Piotroski F-Score	3